2021

• 02 Planning to launch CLIA services in the US

2020

• 06 Selected as a Bio core technology development project by Ministry of Trade, Industry and Energy

2019

• 10 Contracted antibody development project with US Thermofisher
• 10 Officially entered Japan after marketing contract with Japanese CMIC
• 06 Contracted with domestic company W for PDX CTC analysis project

2018

• 11 Listed on KOSDAQ
• 09 Contracted CTC analysis for anti cancer drug
• 08 Contracted CTC analysis project with Samsung Seoul Hospital
• 08 Contracted CTC analysis project with domestic company C pharmaceutical company
• 06 Contracted CTC analysis project with Yonsei Severence Hospital
• 05 Head office relocated to (Beobwon-ro, Songpa-gu, Seoul)
• 03 Contracted CTC analysis project with Seoul St. Mary's Hospital
• 02 4th contract with Daiichi Sankyo

2017

• 12 Signed platform supply contract with Samsung Seoul Hospital
• 09 Contracted with National Cancer Center and ABL Bio to discover biomarkers
• 07 Selected as a Future growth power flagship project by Ministry of Science & Technology (Awarded by Minister of science and ICT)
• 06 3rd contract with Daiichi Sankyo
  Contracted CTC analysis project with Seoul St. Mary's Hospital
  
• 05 Opened local Bio Polis office in Singapore
• 05 Contracted Treatment Effectiveness Project with Seoul St. Mary's Hospital
• 03 GMP certified for in vitro diagnostic medical reagents
  Approval of Isolation Kit in US
  Contracted with ABL BIO for anticancer drug efficacy verification project
  

2016

• 12 INNOBIZ certified by the Ministry of SME
  2nd contract with with Daiichi Sankyo
• 11 Selected as an Industrial convergence leading company
• 10 Selected as a Post genome genetic project by Ministry of Commerce, Industry and Energy, Korea
• 07 Approval of IF Stainer/Time Laps Incubator in US, Japan
  Approval of Cell Image Analyzer in Japan
  First contract with Daiichi Sankyo
  
• 06 Approval of IF Stainer/ Cell Image Analyzer/ Time Laps Incubator in Korea
• 05 Approval of Cell Isolator in China
• 04 Approval of Cell isolator in Korea and Japan
• 04 Approval of medical device manufacturing from the department of Ministry of Health, Labor and Welfare, Japan
• 03 GMP certified of in vitro diagnostic devices
• 03 Approval of cell isolator in Europe
• 02 ISO 13485 certified/ approval of Cell Isolator in the US

2015

• 09 Established CytoGen, Inc., USA (Silicon-Valley in the US)

2014

• 02 Approval of medical device manufacturing and cell separation chip manufacturing by Ministry of Food and Drug Administration

2013

• 10 Selected as a project of strengthening new growing power equipment with competitiveness by Ministry of Commerce, Industry and Energy
• 06 Selected as an Advanced (Convergence) Technology Center (ACT) project by the Ministry of Commerce, Industry and Energy
• 06 Selected as a Technological innovation development project by the ministry of small and medium sized enterprise

2011

• 10 Selected as a First-step component material technology development project
• 10 Started commercial service related to CTC isolations
• 06 Selected as a SME of convergence technology development project
• 01 Registered as a Genetic Testing laboratory

2010

• 09 Established R&D center
  
• 08 Application and approval by IRB, initiating clinical services
• 06 Certified as a Venture enterprise
• 03 Established CytoGen, Inc.

2008

• 01 Designed unique CTC Chips and confirmed reproducibility of CTC isolation using the chip

2006

• 01 R&D on pre/ post-processes for CTC isolations